Bacteriocin-mediated competition in cystic fibrosis lung infections.
about
Parasites and competitors suppress bacterial pathogen synergistically due to evolutionary trade-offs.Determination of Acquired Resistance Profiles of Pseudomonas aeruginosa Isolates and Characterization of an Effective Bacteriocin-Like Inhibitory Substance (BLIS) Against These Isolates.Novel Immunity Proteins Associated with Colicin M-like Bacteriocins Exhibit Promiscuous Protection in Pseudomonas.A Natural Chimeric Pseudomonas Bacteriocin with Novel Pore-Forming Activity Parasitizes the Ferrichrome Transporter.Diversity, Prevalence, and Longitudinal Occurrence of Type II Toxin-Antitoxin Systems of Pseudomonas aeruginosa Infecting Cystic Fibrosis Lungs.Bacterial competition and quorum-sensing signalling shape the eco-evolutionary outcomes of model in vitro phage therapyPyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.Pyoverdin cheats fail to invade bacterial populations in stationary phase.Streptococcus pneumoniae Modulates Staphylococcus aureus Biofilm Dispersion and the Transition from Colonization to Invasive Disease.Bacteriocins and the assembly of natural Pseudomonas fluorescens populations.The Antimicrobial Activity of a Carbon Monoxide Releasing Molecule (EBOR-CORM-1) Is Shaped by Intraspecific Variation within Pseudomonas aeruginosa Populations.A nutrient mediates intraspecific competition between rodent malaria parasites in vivo.Hitting with a BAM: Selective Killing by Lectin-Like Bacteriocins.Generalized Growth of Estuarine, Household and Clinical Isolates of Pseudomonas aeruginosa.Life in the cystic fibrosis upper respiratory tract influences competitive ability of the opportunistic pathogen Pseudomonas aeruginosa
P2860
Q36214728-588FAEEF-9DED-4217-97B0-9B664362C0A2Q37367119-47CDC004-3244-4930-9B0C-0B8BCD4D768EQ37611767-06CBDA21-6EF9-4A60-A962-55E84140CBA7Q37712113-BF222D53-0895-4D08-9638-22734A3EEFDEQ40142398-2C2D8529-E0BB-46BF-94A1-BB84262CE666Q40356497-9D0063B0-7201-4DE3-9F71-889534DB4633Q40696824-FB6B0EE2-8439-4D68-AB42-778502483637Q45950474-091CBCC0-AC65-4B90-ADDB-9B7404DAAC41Q47556309-33D09A42-499D-4B4E-B481-629AC294BBADQ51245452-48A3DB87-AEC5-409F-87BC-DD7125FE5552Q51748626-113F890E-6B57-444E-8A8A-804ADCF79719Q51819158-7E4CFD55-78B6-441A-8E55-E14BB8E730C9Q52348634-2D684644-5287-4FD6-B1F2-9ABC8EBCDCA1Q52620575-BAD878DB-1E65-45D1-992F-ED6441B1E214Q58715300-A08E0783-0F4F-40D1-83B9-599566EF22F7
P2860
Bacteriocin-mediated competition in cystic fibrosis lung infections.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Bacteriocin-mediated competition in cystic fibrosis lung infections.
@en
Bacteriocin-mediated competition in cystic fibrosis lung infections.
@nl
type
label
Bacteriocin-mediated competition in cystic fibrosis lung infections.
@en
Bacteriocin-mediated competition in cystic fibrosis lung infections.
@nl
prefLabel
Bacteriocin-mediated competition in cystic fibrosis lung infections.
@en
Bacteriocin-mediated competition in cystic fibrosis lung infections.
@nl
P2093
P2860
P50
P356
P1476
Bacteriocin-mediated competition in cystic fibrosis lung infections.
@en
P2093
Ashleigh S Griffin
Helle Krogh Johansen
John B Bruce
Martin C J Maiden
Melanie Ghoul
P2860
P356
10.1098/RSPB.2015.0972
P577
2015-09-01T00:00:00Z